摘要
目的 探讨连续性肾脏替代治疗脓毒症患者的临床疗效及对血流感染的作用。方法 研究选取2025年1月-2026年1月在本医院接受治疗的120例脓毒症患者作为研究样本,采取随机数字表法将所有患者进行分组,即对照组采取常规治疗方式(60例)与观察组采取连续性肾脏替代治疗方式(60例),以此比较两组患者的ICU住院时间、总住院时间、器官功能障碍改善情况、临床疗效、血流感染发生率。结果 观察组患者的ICU住院时间和总住院时间短于对照组,差异具有统计学意义(P<0.05);观察组患者器官功能障碍改善情况更优秀,差异具有统计学意义(P<0.05);观察组患者的临床疗效优于对照组,差异具有统计学意义(P<0.05);观察组患者的血流感染发生率低于对照组,差异具有统计学意义(P<0.05)。结论 连续性肾脏替代治疗脓毒症患者能够有效缩短患者ICU住院时间和总住院时间,帮助患者改善器官功能障碍,降低血流感染发生率,提高临床疗效,值得进一步推广应用。
关键词: 连续性肾脏替代治疗;脓毒症患者;临床疗效;血流感染;器官功能障碍
Abstract
Objective To investigate the clinical efficacy of continuous renal replacement therapy in sepsis patients and its effect on bloodstream infections. Methods A total of 120 sepsis patients who received treatment in our hospital from January 2025 to January 2026 were selected as the study sample. The random number table method was used to divide all patients into two groups: the control group received conventional treatment (60 cases) and the observation group received continuous renal replacement therapy (60 cases). The ICU stay, total hospital stay, improvement of organ dysfunction, clinical efficacy, and incidence of bloodstream infections were compared between the two groups of patients. Results The ICU hospitalization time and total hospitalization time of the observation group patients were shorter than those of the control group, and the difference was statistically significant (P<0.05); The observation group showed better improvement in organ dysfunction, with a statistically significant difference (P<0.05); The clinical efficacy of the observation group was better than that of the control group, and the difference was statistically significant (P<0.05); The incidence of bloodstream infection in the observation group was lower than that in the control group, and the difference was statistically significant (P<0.05). Conclusion Continuous renal replacement therapy can effectively shorten the ICU and total hospitalization time of sepsis patients, help improve organ dysfunction, reduce the incidence of bloodstream infections, and enhance clinical efficacy. It is worth further promoting and applying.
Key words: Continuous renal replacement therapy; Sepsis patients; Clinical efficacy; Bloodstream infection; Organ dysfunction
参考文献 References
[1] 王亚茹,陈晨晨,鲍娇丽.连续性肾脏替代疗法联合血液灌流治疗对脓毒症患者生命体征 炎症指标及预后的影响[J]. 山西医药杂志,2026,55(05):343-347.
[2] 刘金涛,杨通菊,杨涛,等.低分子肝素抗凝与连续性肾脏替代治疗老年ICU脓毒症患者的临床效果及安全性[J]. 中国老年学杂志,2026,46(05):866-870.
[3] 陶宁宁,王海超,苏月琴.连续性肾脏替代治疗联合血液灌流对脓毒症急性肾损伤患者的疗效[J]. 基础医学与临床,2026,46(02):267-272.
[4] 曾德智,梅英杰,甘国能,等.脓毒症患者行连续性肾脏替代治疗时低分子肝素抗凝时间延长的影响因素分析[J]. 当代医药论丛,2025,23(27):22-25.
[5] 龙庆铖.连续性肾脏替代治疗联合血液灌流在脓毒症患者中的应用效果[J]. 医药前沿,2025,15(23):80-83.
[6] 吴宝平.连续性肾脏替代治疗在急性呼吸窘迫综合征中的临床应用研究[J]. 系统医学,2025,10(10):82-85.
[7] 魏辰承.连续性肾脏替代治疗对脓毒症急性肾损伤患者炎性因子及心血管事件的影响分析[J]. 中国典型病例大全,2025,19(01):188-191.
[8] 张小婵.连续性肾脏替代疗法联合血必净治疗脓毒症的效果及对患者凝血功能的影响[J]. 大医生,2024,9(19):65-68.
[9] 肖荣,王利秀,李星.连续性肾脏替代治疗联合血液灌流对脓毒症患者疗效的影响[J]. 系统医学,2024,9(16):24-27.